Virtue Capital Management, LLC Corcept Therapeutics Inc Transaction History

Virtue Capital Management, LLC

  • $477 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 15, 2021
SELL
$19.97 - $24.43 $945,279 - $1.16 Million
-47,335 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$23.49 - $30.56 $114,701 - $149,224
-4,883 Reduced 9.35%
47,335 $1.13 Million
Q4 2020

Feb 16, 2021
BUY
$16.78 - $27.3 $876,218 - $1.43 Million
52,218 New
52,218 $1.37 Million

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.3B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Virtue Capital Management, LLC Portfolio

Follow Virtue Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtue Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email